Dr. Andrea R. Whitfield
Claim this profileEast Carolina University
Expert in Brain Tumor
Expert in Tumors
40 reported clinical trials
91 drugs studied
About Andrea R. Whitfield
Education:
- PhD in Educational Leadership from East Carolina University (ECU), 2019.
- MA in Educational Leadership from ECU, 2015.
- BS in Elementary Education from ECU, 2011.
Experience:
- Assistant Professor, Department of Educational Leadership, East Carolina University, since 2020.
- Served as Adjunct Instructor in the same department, 2017-2020.
Area of expertise
1Brain Tumor
Global LeaderStage I
Stage II
Stage IV
2Tumors
Global LeaderStage I
Stage II
Stage IV
Affiliated Hospitals
Clinical Trials Andrea R. Whitfield is currently running
Genetic Testing-Directed Therapy
for Pediatric Cancer
This Pediatric MATCH screening and multi-sub-study phase II trial studies how well treatment that is directed by genetic testing works in pediatric patients with solid tumors, non-Hodgkin lymphomas, or histiocytic disorders that have progressed following at least one line of standard systemic therapy and/or for which no standard treatment exists that has been shown to prolong survival. Genetic tests look at the unique genetic material (genes) of patients' tumor cells. Patients with genetic changes or abnormalities (mutations) may benefit more from treatment which targets their tumor's particular genetic mutation, and may help doctors plan better treatment for patients with solid tumors or non-Hodgkin lymphomas.
Recruiting1 award Phase 214 criteria
Selumetinib vs. Chemotherapy
for Brain Cancer
This trial is comparing a new drug, selumetinib, with standard chemotherapy to treat patients with a specific type of brain tumor. The patients do not have a certain genetic mutation and are not affected by a genetic disorder. Selumetinib works by blocking enzymes needed for tumor growth, while the standard drugs kill or stop tumor cells from dividing.
Recruiting2 awards Phase 3
More about Andrea R. Whitfield
Clinical Trial Related7 years of experience running clinical trials · Led 40 trials as a Principal Investigator · 23 Active Clinical TrialsTreatments Andrea R. Whitfield has experience with
- Cyclophosphamide
- Radiation Therapy
- Etoposide
- Vincristine Sulfate
- Doxorubicin Hydrochloride
- Methotrexate
Breakdown of trials Andrea R. Whitfield has run
Brain Tumor
Tumors
Leukemia
Neuroblastoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Andrea R. Whitfield specialize in?
Andrea R. Whitfield focuses on Brain Tumor and Tumors. In particular, much of their work with Brain Tumor has involved Stage I patients, or patients who are Stage II.
Is Andrea R. Whitfield currently recruiting for clinical trials?
Yes, Andrea R. Whitfield is currently recruiting for 19 clinical trials in Greenville North Carolina. If you're interested in participating, you should apply.
Are there any treatments that Andrea R. Whitfield has studied deeply?
Yes, Andrea R. Whitfield has studied treatments such as Cyclophosphamide, Radiation Therapy, Etoposide.
What is the best way to schedule an appointment with Andrea R. Whitfield?
Apply for one of the trials that Andrea R. Whitfield is conducting.
What is the office address of Andrea R. Whitfield?
The office of Andrea R. Whitfield is located at: East Carolina University, Greenville, North Carolina 27834 United States. This is the address for their practice at the East Carolina University.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.